A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409

Japan Esophageal Oncology Group/Japan Clinical Oncology Group, Hiroya Takeuchi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A randomized Phase III study was commenced in May 2015 to confirm the non-inferiority of thoracoscopic esophagectomy to open esophagectomy in terms of overall survival for clinical Stage I-III esophageal cancer. A total of 300 patients will be accrued from Japanese institutions over 6 years. The primary endpoint is overall survival. The secondary endpoints are relapse-free survival, proportion of patients with R0 resection, proportion of patients who underwent re-operation, adverse events, postoperative respiratory function change, postoperative quality-of-life score (EORTC QLQC30), and proportion of patients who need conversion from thoracoscopic surgery to open surgery. This trial has been registered in the UMIN Clinical Trials Registry as UMIN000017628.

Original languageEnglish
Article numberhyv178
Pages (from-to)174-177
Number of pages4
JournalJapanese Journal of Clinical Oncology
Volume46
Issue number2
DOIs
Publication statusPublished - 2016 Feb 1

Fingerprint

Esophagectomy
Medical Oncology
Esophageal Neoplasms
Japan
Thorax
Survival
Conversion to Open Surgery
Thoracoscopy
Registries
Quality of Life
Clinical Trials
Recurrence

Keywords

  • Open esophagectomy
  • Phase III
  • Thoracoscopic esophagectomy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Radiology Nuclear Medicine and imaging

Cite this

A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer : Japan Clinical Oncology Group Study JCOG1409. / Japan Esophageal Oncology Group/Japan Clinical Oncology Group; Takeuchi, Hiroya.

In: Japanese Journal of Clinical Oncology, Vol. 46, No. 2, hyv178, 01.02.2016, p. 174-177.

Research output: Contribution to journalArticle

Japan Esophageal Oncology Group/Japan Clinical Oncology Group ; Takeuchi, Hiroya. / A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer : Japan Clinical Oncology Group Study JCOG1409. In: Japanese Journal of Clinical Oncology. 2016 ; Vol. 46, No. 2. pp. 174-177.
@article{652c5a6fbbd641aa929bfe0d8ed1f895,
title = "A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer: Japan Clinical Oncology Group Study JCOG1409",
abstract = "A randomized Phase III study was commenced in May 2015 to confirm the non-inferiority of thoracoscopic esophagectomy to open esophagectomy in terms of overall survival for clinical Stage I-III esophageal cancer. A total of 300 patients will be accrued from Japanese institutions over 6 years. The primary endpoint is overall survival. The secondary endpoints are relapse-free survival, proportion of patients with R0 resection, proportion of patients who underwent re-operation, adverse events, postoperative respiratory function change, postoperative quality-of-life score (EORTC QLQC30), and proportion of patients who need conversion from thoracoscopic surgery to open surgery. This trial has been registered in the UMIN Clinical Trials Registry as UMIN000017628.",
keywords = "Open esophagectomy, Phase III, Thoracoscopic esophagectomy",
author = "{Japan Esophageal Oncology Group/Japan Clinical Oncology Group} and Hiroya Takeuchi and Hiroya Takeuchi and Junki Mizusawa and Masahiko Ando and Yasuhiro Tsubosa and Kazuo Koyanagi and Hiroyuki Daiko and Satoru Matsuda and Kenichi Nakamura and Ken Kato and Yuko Kitagawa",
year = "2016",
month = "2",
day = "1",
doi = "10.1093/jjco/hyv178",
language = "English",
volume = "46",
pages = "174--177",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - A randomized Phase III trial of thoracoscopic versus open esophagectomy for thoracic esophageal cancer

T2 - Japan Clinical Oncology Group Study JCOG1409

AU - Japan Esophageal Oncology Group/Japan Clinical Oncology Group

AU - Takeuchi, Hiroya

AU - Takeuchi, Hiroya

AU - Mizusawa, Junki

AU - Ando, Masahiko

AU - Tsubosa, Yasuhiro

AU - Koyanagi, Kazuo

AU - Daiko, Hiroyuki

AU - Matsuda, Satoru

AU - Nakamura, Kenichi

AU - Kato, Ken

AU - Kitagawa, Yuko

PY - 2016/2/1

Y1 - 2016/2/1

N2 - A randomized Phase III study was commenced in May 2015 to confirm the non-inferiority of thoracoscopic esophagectomy to open esophagectomy in terms of overall survival for clinical Stage I-III esophageal cancer. A total of 300 patients will be accrued from Japanese institutions over 6 years. The primary endpoint is overall survival. The secondary endpoints are relapse-free survival, proportion of patients with R0 resection, proportion of patients who underwent re-operation, adverse events, postoperative respiratory function change, postoperative quality-of-life score (EORTC QLQC30), and proportion of patients who need conversion from thoracoscopic surgery to open surgery. This trial has been registered in the UMIN Clinical Trials Registry as UMIN000017628.

AB - A randomized Phase III study was commenced in May 2015 to confirm the non-inferiority of thoracoscopic esophagectomy to open esophagectomy in terms of overall survival for clinical Stage I-III esophageal cancer. A total of 300 patients will be accrued from Japanese institutions over 6 years. The primary endpoint is overall survival. The secondary endpoints are relapse-free survival, proportion of patients with R0 resection, proportion of patients who underwent re-operation, adverse events, postoperative respiratory function change, postoperative quality-of-life score (EORTC QLQC30), and proportion of patients who need conversion from thoracoscopic surgery to open surgery. This trial has been registered in the UMIN Clinical Trials Registry as UMIN000017628.

KW - Open esophagectomy

KW - Phase III

KW - Thoracoscopic esophagectomy

UR - http://www.scopus.com/inward/record.url?scp=84961612875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961612875&partnerID=8YFLogxK

U2 - 10.1093/jjco/hyv178

DO - 10.1093/jjco/hyv178

M3 - Article

C2 - 26732383

AN - SCOPUS:84961612875

VL - 46

SP - 174

EP - 177

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 2

M1 - hyv178

ER -